June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate (Pradaxa) anticoagulant oral pellets as the first oral anticoagulant to treat children ...
Deep Vein Thrombosis (DVT)
Deep vein thrombosis (DVT) is caused by the formation of venous blood clots in the arms and legs. This page includes information on technologies to treat DVT using catheter based interventions and thrombolysis.
-
-
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an overview of numerous trials in progress testing a variety of anticoagulants and ...
-
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding stent system. This device is indicated for use in the iliofemoral veins in patients ...
-
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat ...
November 21, 2022 — New research published in the Journal of the American College of Cardiology shows the use of drug ...
November 21, 2022
October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...
October 31, 2022
October 14, 2022
Feature | Thrombectomy Devices | By Global Market Insights
The global thrombectomy devices market is poised to experience substantial expansion, owing to the emergence of ...
June 27, 2022
May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...
May 20, 2022
January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 ...
January 10, 2022
June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...
June 21, 2021
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an ...
April 01, 2021
Feature | Antiplatelet and Anticoagulation Therapies | By Dave Fornell, Editor
A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...
March 22, 2021
January 8, 2021 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc ...
January 08, 2021
December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants ...
December 23, 2020
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding ...
October 26, 2020
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials ...
September 11, 2020
May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of ...
May 04, 2020
December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of ...
December 27, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now